Fluticasone/Formoterol/Glycopyrronium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluticasone/Formoterol/Glycopyrronium, covering 2025-02-14 to 2025-02-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) [Phase 3]